Cefepime "Jonckheere"
Indication: Severe Gram-negative and nosocomial infections in critically ill ICU patients
Population PK simulator for cefepime continuous infusion in critically ill adults. Two-compartment model with renal function and body size effects for target-controlled infusion and beta-lactam PK/PD target attainment.
Drug Overview
Clinical Context
- Molecular Target
- Bacterial penicillin-binding proteins
- Drug Class
- Beta-Lactam Antibiotic (4th-gen Cephalosporin)
- Therapeutic Area
- Infectious Disease / Critical Care
- Indication
- Severe Gram-negative and nosocomial infections in critically ill ICU patients
- Route of Administration
- IV continuous infusion
Model Information
- Model Type
- Population PK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Cefepime "Jonckheere" allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK model characterizes the pharmacokinetics of this beta-lactam antibiotic (4th-gen cephalosporin) following iv continuous infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Cefepime "Jonckheere" PK simulator?
This is a free, interactive pharmacokinetic simulator for Cefepime "Jonckheere" used in Severe Gram-negative and nosocomial infections in critically ill ICU patients. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Cefepime "Jonckheere" belong to?
Cefepime "Jonckheere" is classified as a Beta-Lactam Antibiotic (4th-gen Cephalosporin) that targets Bacterial penicillin-binding proteins. It is used in the Infectious Disease / Critical Care therapeutic area.
What route of administration does this model simulate?
This simulator models IV continuous infusion administration of Cefepime "Jonckheere". The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Cefepime "Jonckheere" simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community